Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Completed
CT.gov ID
NCT02618070
Collaborator
(none)
30
1
2
13
2.3

Study Details

Study Description

Brief Summary

In this functional magnetic resonance imaging study, effects of different information of fat content of high or low fat will be examined in FD patients and healthy volunteers (n=30, respectively). These data will provide a better understanding of symptom generation following food ingestion in general as well as in patients with respective functional gastrointestinal disorders.

Condition or Disease Intervention/Treatment Phase
  • Other: Yogurt
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Apr 1, 2017
Actual Study Completion Date :
Apr 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Functional dyspepsia patient

Yogurt ingestion

Other: Yogurt

Experimental: Healthy

Yogurt ingestion

Other: Yogurt

Outcome Measures

Primary Outcome Measures

  1. functional brain activity [1-2 years]

    Resting BOLD (Blood oxygenation level-dependent) signal before and after yogurt ingestion will compared between groups. There is a small risk of discomfort from claustrophobia, periods of immobility, and exposure to the noise of the magnet. The investigators will offer the participants ear plugs. In rare cases the participants experience dizziness, nausea, or tinnitus which normally disappear after the measurement. During the measurements there is the possibility of warming which could lead to skin irritation in people with tattoos. Therefore, the participants with tattoos will not be included. The participants are instructed to tell the investigators immediately if any uncomforted appears. The study will be performed by experienced experimenters who know all about the risks. During the measurements, the participants are monitored. As a commercial yogurt (200 ml) will be used, the investigators do not expect any side effects. Food allergy will be checked before.

  2. subjective rating [1-2 years]

    The investigators will measure how much the participants have fullness, satiation, nausea and vomiting, pain, and their mood before and after the yogurt ingestion using visual analog scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male and female, volunteering adults BMI: 18-25 kg/m² right-handed Age: 18-65 years Capacity to give informed consent

For FD patients, Diagnosis of functional dyspepsia over the last 12 months certified by a medical record Inconspicuous gastroscopy during the last 6 months certified by a medical record

Exclusion Criteria:
  • Subjects which have a non-removable metal object in or at their body, such as, for example:

  • Heart pace-maker,

  • Artificial heart valve,

  • Metal prosthesis,

  • Metallic implants (screws, plates from operations, etc.),

  • Interuterine Spiral,

  • Metalsplinters / grenade fragments

  • Non-removable dental braces,

  • Acupuncture needles,

  • Insulin pump,

  • Intraport, etc., Pregnant women or pregnancy cannot be excluded Nursing women Subjects with limited temperature perception and/or increased sensitivity to warming of the body A circulatory disease cannot be excluded Subjects with hearing-disease or an increased sensitivity to loud noises Subjects with fear of closed-in places (claustrophobia) Subjects which were operated less than three month ago Acute illness or infection Neurological disorder or injury (e.g. epilepsy) Moderate or severe head injury Severe psychotic illness (e.g. schizophrenia, depression) Intake of antidepressants / antipsychotics Vegetarians/Vegans Food allergies Self-reported eating disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany Tuebingen Germany 72072

Sponsors and Collaborators

  • University Hospital Tuebingen

Investigators

  • Principal Investigator: Paul Enck, Prof., Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Inseon Lee, MS, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT02618070
Other Study ID Numbers:
  • 633/2015BO2
First Posted:
Dec 1, 2015
Last Update Posted:
Apr 6, 2017
Last Verified:
Apr 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2017